Induction of cytochrome P-450BM-3 (CYP 102) by non-steroidal anti-inflammatory drugs in Bacillus megaterium

Biochemical Journal

Volumn 316, Issue 1, 1996, Pages 279-283

  English, Neil ^a   Hughes, Valerie ^a   Wolf, C Roland ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BARBITURIC ACID DERIVATIVE; CYTOCHROME P450; IBUPROFEN; INDOMETACIN; KETOPROFEN; NONSTEROID ANTIINFLAMMATORY AGENT; PEROXISOME PROLIFERATOR; TRANSCRIPTION FACTOR; UNSPECIFIC MONOOXYGENASE;

ARTICLE; BACILLUS MEGATERIUM; CONTROLLED STUDY; MULTIGENE FAMILY; NONHUMAN; OPERATOR GENE; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION; TRANSCRIPTION REGULATION;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BACILLUS MEGATERIUM; BACTERIAL PROTEINS; BASE SEQUENCE; CYTOCHROME P-450 ENZYME SYSTEM; ENZYME INDUCTION; GENE EXPRESSION; IBUPROFEN; INDOMETHACIN; KETOPROFEN; KINETICS; MAMMALS; MIXED FUNCTION OXYGENASES; MOLECULAR SEQUENCE DATA; OLIGODEOXYRIBONUCLEOTIDES; REPRESSOR PROTEINS; TRANSCRIPTION FACTORS;

EID: 0029941132     PISSN: 02646021     EISSN: None     Source Type: Journal    
DOI: 10.1042/bj3160279     Document Type: Article

References (28)

1. Okey, A. B. (1992) in Pharmacogenetics and Drug Metabolism (Kalow, W., ed.), pp. 549-608, Pergamon Press, New York
2. Lock, E. A., Mitchell, A. M. and Elcombe, C. R. (1989) Annu. Rev. Pharmacol. Toxicol. 29, 145-163
3. Reddy, J. K. and Lalwani, N. D. (1983) CRC Crit. Rev. Toxicol. 12, 1-58
4. Orton, T. C. and Parker, G. L. (1982) Drug Metab. Dispos. 10, 110-115
5. Issemann, I. and Green, S. (1990) Nature (London) 347, 645-649
6. Green, S. (1992) Cancer Surv. 14, 221-232
7. Nahri, L. O. and Fulco, A. J. (1982) J. Biol. Chem. 257, 2147-2150
8. Porter, T. D. (1991) Trends Biochem. Sci. 16, 154-158
9. Nebert, D. W., Nelson, D. R. and Feyereisen, R. (1989) Xenobiotica 19, 1149-1160
10. Shaw, G. C. and Fulco, A. J. (1992) J. Biol. Chem. 267, 5515-5526
11. English, N., Hughes, V. and Wolf, C. R. (1994) J. Biol. Chem. 269, 26836-26841
12. Rang, H. P. and Dale, M. M. (1991) Pharmacology, pp. 281-298. Churchill Livingstone, Edinburgh
13. Wallace, J. L. and Cirino, G. (1994) Trends Pharmacol. Sci. 15, 405-406
14. Vane, J. R. (1971) Nature (London) 231, 232-235
15. Xiaolao, Q. and Hall, S.D. (1993) J. Pharmacol. Exp. Ther. 266, 845-851
16. Ayrton, A. D., Ioannides, C. and Parke, D. V. (1991) Biochem. Pharmcol. 42, 109-115
17. Rekka, E., Ayalogu, E. O., Lewis, D. F., Gibson, G. G. and Ioannides, C. (1994) Arch. Toxicol. 68, 73-78
18. Grelet, N. (1951) Ann. Inst. Pasteur (Paris) 81, 430-440
19. Lowry, O. H., Rosebrough, N. J., Farr, A. L. and Randall, R. J. (1951) J. Biol. Chem. 193, 265-275
20. Ruettinger, R. T. and Fulco, A. J. (1981) J. Biol. Chem. 256, 5728-5734
21. Omura, T. and Sato, R. (1964) J. Biol. Chem. 239, 2379-2385
22. Towbin, H., Staehelin, T. and Gordon, J. (1979) Proc. Natl. Acad. Sci. U.S.A. 76, 4350-4354
23. Laemmli, U.K. (1970) Nature (London) 227, 680-685
24. Lewis, A. D., Hickson, I. D., Robson, C. N., Harris, A. L. Hayes, J. D., Griffiths, S. A., Manson, M. M., Hall, A. E., Moss, J. E. and Wolf, C. R. (1988) Proc. Natl. Acad. Sci. U.S.A. 85, 8511-8515
25. Workman, J. L. and Abmayr, S. M. (1993) in Current Protocols in Molecular Biology (Ausubel, F., Brent, R., Kingston, R., Moore, D., Seidman, J., Smith, J. and Struhl, K., eds.), vol. 2, sections 12.2.1-12.2.7, Greene Publishing Co. and John Wiley and Sons Inc., New York
26. Hertz, R., Berman, I. and Bar-Tana, J. (1994) Eur. J. Biochem. 221, 611-616
27. Henry, M. F. and Cronin, J. E., Jr. (1992) Cell 70, 671-679
28. Eacho, P. I., Foxworthy, P. S., Johnson, W. D., Hoover, D. M. and White, S. L. (1986) Toxicol. Appl. Pharmacol. 83, 430-437